InsidersTradesSigma
Track the Telomir Pharmaceuticals, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €74.3m. The latest transaction was filed on 24 April 2026 (J). Among the most active insiders: Aminov Erez. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Telomir Pharmaceuticals, Inc. es una empresa farmacéutica centrada en el desarrollo de tratamientos innovadores basados en la biología de los telómeros. Cotiza en el NASDAQ bajo el ticker XNAS.